Allena Pharmaceuticals Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Allena Pharmaceuticals prevailing Real Value cannot be determined due to lack of data. The current price of Allena Pharmaceuticals is $0.0. Our model approximates the value of Allena Pharmaceuticals from analyzing the firm fundamentals such as Return On Equity of -5.41, shares owned by insiders of 0.92 %, and Current Valuation of (181.84 K) as well as examining its technical indicators and probability of bankruptcy.
Allena Pharmaceuticals Total Value Analysis
Allena Pharmaceuticals is presently forecasted to have takeover price of (181.84 K) with market capitalization of 244.17 K, debt of 5.28 M, and cash on hands of 6.59 M. The negative valuation of Allena Pharmaceuticals may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should thoroughly investigate all of the Allena Pharmaceuticals fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(181.84 K) | 244.17 K | 5.28 M | 6.59 M |
Allena Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Allena is to check how much profit was generated for every dollar of assets it reports. Allena Pharmaceuticals shows a negative utilization of assets of -1.07 percent, losing $0.0107 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Allena Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Allena Pharmaceuticals Ownership Allocation
Allena Pharmaceuticals holds a total of 122.08 Million outstanding shares. Almost 98.82 percent of Allena Pharmaceuticals outstanding shares are held by general public with 0.92 (percent) owned by insiders and only 0.26 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Allena Pharmaceuticals Profitability Analysis
Net Loss for the year was (48.66 M) with profit before overhead, payroll, taxes, and interest of 0.Allena Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Allena Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 83 M | |
| Retained Earnings | -246.5 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in Allena Pink Sheet
If you are still planning to invest in Allena Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allena Pharmaceuticals' history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |